The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome
Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Patients with an myofascial trigger point (MTrP) in their upper trapezius will be divided
into three groups: Group A receiving MTrP injection with normal saline (control group), Group
B with hypo-osmolar dextrose (5% dextrose), and Group C with hyper-osmolar dextrose (15%
dextrose). Clinical outcomes and morphological changes will be measured before the injection,
one hour after, one week after, two weeks after, and one month after the injection to
delineate the therapeutic effects of dextrose injection for an MTrP.